Title

Heteromer Stars for the Treatment of Breast Cancer

Presenter Information

Caitlin Brocker

Department

Chemical and Biochemical Engineering

Major

Biochemical Engineering

Research Advisor

Barua, Sutapa

Advisor's Department

Chemical and Biochemical Engineering

Funding Source

Start Up of Dr. Barua; OURE Program

Abstract

A star-like structure has potential to carry large quantities of a therapeutic agent, improve adherence to target cells and safely release drugs after prolonged period of residence at the diseased site. However, synthesis of such a stellate structure is not an easy task. Here, the design of a polylactide-co-glycolic acid (PLGA) based star shape conformation is described for the treatment of breast cancer. About 1 in 8 U.S. women (12%) develops invasive breast cancer over the course of her lifetime. In 2016, an estimated 246,660 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S., along with 61,000 new cases of non-invasive (in situ) breast cancer. Although a variety of nanoparticles have been tested in lab scale, the use of heteromer armed nanoparticles presents a unique drug release matrix. PLGA is a biocompatible polymer that enables controlled release of tetrakis(hydroxymethyl) phosphonium chloride (THPC) drugs into breast cancer cells. This novel delivery platform significantly inhibits the breast cancer cell growth population that potentiates the efficacy of THPC treatment.

Biography

Caitlin Brocker is a senior and will complete her B.S. in Chemical Engineering with a Biochemical Emphasis at Missouri University of Science and Technology in May. Caitlin is also on the Missouri S&T Women’s Volleyball Team and the Love Your Melon Campus Crew. She has been working in Dr. Sutapa Barua’s lab since April 2015, and her projects have involved drug delivery systems for breast cancer treatment. Caitlin has published one paper in the journal Nanotechnology (impact factor = 3.573) in 2017 and is preparing one more that will be submitted in 2017. She won 3rd place in the Engineering oral presentation in the 2016 OURE research meeting.

Research Category

Engineering

Presentation Type

Oral Presentation

Document Type

Presentation

Location

Missouri Room

Start Date

4-11-2017 9:30 AM

End Date

4-11-2017 10:00 AM

This document is currently not available here.

Share

COinS
 
Apr 11th, 9:30 AM Apr 11th, 10:00 AM

Heteromer Stars for the Treatment of Breast Cancer

Missouri Room

A star-like structure has potential to carry large quantities of a therapeutic agent, improve adherence to target cells and safely release drugs after prolonged period of residence at the diseased site. However, synthesis of such a stellate structure is not an easy task. Here, the design of a polylactide-co-glycolic acid (PLGA) based star shape conformation is described for the treatment of breast cancer. About 1 in 8 U.S. women (12%) develops invasive breast cancer over the course of her lifetime. In 2016, an estimated 246,660 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S., along with 61,000 new cases of non-invasive (in situ) breast cancer. Although a variety of nanoparticles have been tested in lab scale, the use of heteromer armed nanoparticles presents a unique drug release matrix. PLGA is a biocompatible polymer that enables controlled release of tetrakis(hydroxymethyl) phosphonium chloride (THPC) drugs into breast cancer cells. This novel delivery platform significantly inhibits the breast cancer cell growth population that potentiates the efficacy of THPC treatment.